Mark  Hamner  to  Adrenergic alpha-2 Receptor Antagonists
                            
                            
                                This is a "connection" page, showing publications  Mark  Hamner  has written about  Adrenergic alpha-2 Receptor Antagonists.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.577
         
        
        
     
 
    
        
        - 
            Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn Behav Ther. 2018 09; 47(5):351-371.
            
            
                Score: 0.577
             
 
                                        
                                
                             
                         
                        
                            
                                
                                    
                                                Connection Strength  
 The connection strength for concepts is the sum of the scores for each matching publication.  
   Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.